Skip to main content
OpenTrials

Clinical trial condition

NSCLC, Stage III

Explore clinical trials studying NSCLC, Stage III. Study availability and eligibility vary by location and protocol.

13 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

NSCLC, Stage III trial results

Recruiting

Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC

NCT06552234

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • CH Aix-en-Provence Aix-en-Provence, Bouches Du Rhône, France
  • AP-HM Marseille, Bouches Du Rhône, France
  • HIA Sainte Anne Toulon, Var, France
  • CHU Angers Angers, France
View all 20 locations
View Trial Details
Recruiting

Lung Cancer Registry

NCT04654364

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Universitätsklinik für Innere Medizin III, PMU Salzburg Salzburg, State of Salzburg, Austria
  • Univ.-Klinik für Innere Medizin V, Hämatologie/Onkologie LKH-Innsbruck / Universitätskliniken Innsbruck, Tyrol, Austria
  • Kepler Universitätsklinikum GmbH, Med. Campus III, Klinik für Lungenheilkunde / Pneumologie Linz, Upper Austria, Austria
View Trial Details
Recruiting

A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

NCT06467383

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • IRCCS Casa di sollievo dalla sofferenza San Giovanni Rotondo, FG, Italy
  • ASST degli Spedali Civili di Brescia Brescia, Italy
  • Gemelli Molise Campobasso, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
View all 25 locations
View Trial Details
Completed

Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy

NCT04351256

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Universitätsklinikum Aachen Aachen, Germany
  • DRK Kliniken Berlin-Mitte Berlin, Germany
  • Kliniken der Stadt Köln gGmbH, Lungenklinik Merheim Cologne, Germany
  • Universitätsmedizin Göttingen Göttingen, Germany
View all 14 locations
View Trial Details

Related conditions